NOT-HL-23-074: Notice of Early Expiration of NOT-HL-21-017, "Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)"

Notice of Early Expiration of NOT-HL-21-017, "Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)"

Notice Number:

NOT-HL-23-074

Key Dates

Release Date:

January 31, 2023

Related Announcements

PA-20-185 - NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

This Notice informs applicants of the early expiration of NOT-HL-21-017 "Notice of Special Interest (NOSI): Integrative Omics Analysis of NHLBI TOPMed Data (Parent R01 Clinical Trial Not Allowed)", effective March 6, 2023. Any application accepted for a receipt date prior to this expiration will be considered.

NHLBI intends to reissue the TOPMed NOSI in Winter/Spring 2023.

Inquiries

Please direct all inquiries regarding this Notice to:

James Luo, Ph.D.
Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0533
Email: [email protected]

Huiqing Li, Ph.D.
Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0448
Email: [email protected]

Weiniu Gan, Ph.D.
Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0202
Email: [email protected]

Pankaj Qasba, Ph.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0050
Email: [email protected]